Mirror checks and photographs feel unchanged despite significant objective loss
This biochemical evidence strongly supports that Retatrutide not only suppresses inflammation transcriptionally but also actively restores lipid mediator balance, contributing to immune resolution
Current access is limited to clinical trials and research peptide suppliers
How your body naturally produces GLP-1 Our bodies naturally produce GLP-1 in the gut when we eat
Lipid profile improvements (TRIUMPH-4): Non-HDL cholesterol: Clinically meaningful reduction Triglycerides: Significant reduction hsCRP (inflammatory marker): Significant reduction HDL cholesterol: Not significantly improved (consistent with Phase 2 findings) The triglyceride reduction is particularly notable and likely related to glucagon receptor activation, which enhances fat oxidation
Retatrutide (LY3437943) is an investigational triple hormone receptor agonist that activates: GLP-1 (glucagon-like peptide-1) receptor GIP (glucose-dependent insulinotropic polypeptide) receptor Glucagon (GCG) receptor This triple G mechanism targets multiple pathways for appetite control, insulin sensitivity, glucose regulation, and energy/fat metabolismpotentially offering greater effects than dual (GLP-1/GIP) or single agonists
